Difference between revisions of "Template:SPCaripiprazoleLA"
From Psychiatrienet
(Created page with '* More information is in the summary of product characteristics (SPC). <ref>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002755/WC5001561...') |
|||
(7 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | * More information | + | * More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref> |
+ | * Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months). |
Latest revision as of 13:33, 20 February 2025
- More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. [1]
- Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months).